Aurora Spine’s Patent Related to Its Polyaxial ZIP® ISP Allowed by the United States Patent Office
January 13 2017 - 9:01AM
Aurora Spine Corporation (TSXV:ASG) announced today the allowance
of its United States Patent Application No.: 14/732,240 entitled
“POLYAXIAL INTERSPINOUS FUSION IMPLANT AND BONE GROWTH STIMULATION
SYSTEM.” In addition to Aurora’s implant family of ZIP®
ISPs, including its ZIP Ultra®, ZIP 51™, ZIP LP™ and Dyna-ZIP™,
this patent application covers the company’s first polyaxial
implant design.
“The polyaxial ZIP® Interspinous patent
allowance is another milestone in Aurora Spine’s history. Our
latest patent will be issued for our newest interspinous device
design that permits for full polyaxial maneuverability of the
implant components in difficult situations during minimally
invasive fusion cases. The newly allowed patent features our
already patented ONE-STEP™ locking mechanism that eliminates the
use of a set screw in Aurora’s Screwless Procedure™ surgeries,”
said Laszlo Garamszegi, Chief Technology Officer of Aurora
Spine.
“Aurora is changing spine surgery, and we are
thrilled that our newest patent has been allowed by the United
States Patent and Trademark Office (USPTO). This patent further
validates the modern advancements of our Screwless technology,”
said Trent Northcutt, President and CEO of Aurora Spine, “and it
maintains our commitment to introduce advanced, minimally invasive
spine surgery technologies.”
This is Aurora’s second allowed U.S.
patent. Aurora Spine has several other U.S. and international
patent applications pending directed to the ZIP system and its
future technologies.
About Aurora Spine
Aurora Spine is an early stage company focused
on bringing new solutions to the spinal implant market through a
series of screwless, innovative, minimally invasive, regenerative
spinal implant technologies. Aurora Spine continues to
position itself at the forefront of spinal surgery procedures,
focusing on minimally invasive spine surgery technologies.
Aurora Spine is changing spine surgery by focusing on disruptive
technologies following the Company’s commitment to – Simplifying
the Complex.
Forward-Looking Statements
This news release contains forward-looking
information that involves substantial known and unknown risks and
uncertainties, most of which are beyond the control of Aurora
Spine, including, without limitation, those listed under "Risk
Factors" and "Cautionary Statement Regarding Forward-Looking
Information" in Aurora Spine's final prospectus (collectively,
"forward-looking information"). Forward-looking information in this
news release includes information concerning the proposed use and
success of the company’s products in surgical procedures. Aurora
Spine cautions investors of Aurora Spine's securities about
important factors that could cause Aurora Spine's actual results to
differ materially from those projected in any forward-looking
statements included in this news release. Any statements that
express, or involve discussions as to, expectations, beliefs,
plans, objectives, assumptions or future events or performance are
not historical facts and may be forward-looking and may involve
estimates, assumptions and uncertainties which could cause actual
results or outcomes to differ unilaterally from those expressed in
such forward-looking statements. No assurance can be given that the
expectations set out herein will prove to be correct and,
accordingly, prospective investors should not place undue reliance
on these forward looking statements. These statements speak only as
of the date of this press release and Aurora Spine does not assume
any obligation to update or revise them to reflect new events or
circumstances.
For more information, please contact:
Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
(760) 424-2004
Eric Fronk
Chief Financial Officer
(760) 424-2004
www.aurora-spine.com
Aurora Spine (TSXV:ASG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aurora Spine (TSXV:ASG)
Historical Stock Chart
From Apr 2023 to Apr 2024